116 results
8-K
EX-10.1
EYPT
EyePoint Pharmaceuticals Inc
10 Jul 23
EyePoint Pharmaceuticals Announces Chief Executive Officer Transition
7:05am
8-K
EX-10.2
EYPT
EyePoint Pharmaceuticals Inc
10 Jul 23
EyePoint Pharmaceuticals Announces Chief Executive Officer Transition
7:05am
8-K
EX-10.1
sors9jh7q
21 Jun 23
Departure of Directors or Certain Officers
7:53am
8-K
EX-10.1
hmp0a9xp
18 May 23
EyePoint Pharmaceuticals Announces Sale of YUTIQ® to Alimera Sciences, Inc. for $82.5 Million Cash Plus Royalties
7:06am
8-K
EX-10.2
qotv05fwr 0511m43
6 Jan 23
EyePoint Pharmaceuticals Provides Business Update and Key 2023 Clinical Timelines
5:03pm
8-K
EX-10.1
92jq eg93
6 Jan 23
EyePoint Pharmaceuticals Provides Business Update and Key 2023 Clinical Timelines
5:03pm
8-K
EX-10.3
sx2ophqngz1ssnx
6 Jan 23
EyePoint Pharmaceuticals Provides Business Update and Key 2023 Clinical Timelines
5:03pm
8-K
EX-10.4
mkl0fbd2ahatnjzfyb2v
6 Jan 23
EyePoint Pharmaceuticals Provides Business Update and Key 2023 Clinical Timelines
5:03pm
8-K
EX-10.1
alat3rvtlliv90mph
14 Nov 22
Departure of Directors or Certain Officers
8:30am